It works by binding to the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary, triggering a calcium/PKC signaling cascade that releases stored growth hormone, while separately blunting somatostatin's inhibitory signal
However, it is contraindicated for those with certain health conditions and is far less effective for individuals with methylation impairments
For physicians, pharmacists, and other healthcare professionals, this is an important opportunity to follow the evolving science, understand the regulatory process, and prepare for potential changes that may affect clinical practice
It resulted in acne, palpitations, anxiety, uncontrollable movements, facial redness, headache, and insomnia